Duan Luntao, Su Shuai, Wang Yixin, Li Sifei, Sun Peng, Chen Wenqing, Cui Zhizhong
Wei Sheng Wu Xue Bao. 2014 Nov 4;54(11):1353-61.
To evaluate and compare the immunoprotection between a meq-deleted Marek's disease virus (MDV) and CVI988/Rispens against MDV very virulent strain GX0101.
In total 120 one-day-old SPF chickens were divided into 4 groups (30 each) and kept in 5 isolators with positive pressure-filtered air. At 1 day of age, 2000 PFU of SC9-1 was inoculated subcutaneously into each bird in group 1; 2000 PFU of commercial vaccine CVI988/ Rispens was inoculated subcutaneously into each bird in group 2. No viral challenge was made in group 3 and 4 as controls. Five days later chickens in group 1, 2, 3 were challenged intra-abdominally with 2000 PFU of very virulent MDV strain GX0101. During 90 days after challenge, all dead birds were recorded and checked for necropsy. The tumor-suspected tissues were examined by histopathological biopsy. The antibody titers induced by AIV and NDV vaccination and propagation dynamics of MDV GX0101 were detected. At the same time, parallel tests were performed on Hy-Line Brown chickens containing MDV maternal antibody.
SC9-1 stain provided 100% protective efficiency against very virulent GX0101 challenge in SPF and Hy-Line Brown chickens. CVI988/Rispens provided 86. 7% protective efficiency against very virulent GX0101 challenge in SPF chickens and 93% in Hy-Line Brown chickens. Challenge with GX0101 caused 53.3% mortality and 16.7% of birds with gross tumors in SPF chickens while there was 36.7% mortality and 16.7% of birds with gross tumors in Hy-Line Brown chickens, and there was no tumor lesion in histopathological biopsy in control group. The results of qPCR demonstrated that the copies of GX0101 viral genomes in SC9-1 vaccinated chickens was lower than CVI988/Rispens vaccinated chickens in lymphocyte and feather follicle DNA. The results of hemagglutination inhibition test demonstrated that antibody titers of AIV and NDV was higher in SC9-1 vaccinated chickens than that in CVI988/Rispens vaccinated chickens.
SC9-1 stain's immunoprotection against MDV is more effective than CVI988/Rispens strain's both in SPF chickens and commercial Hy-Line Brown chickens containing maternal antibody.
评估并比较缺失meq基因的马立克氏病病毒(MDV)与CVI988/Rispens疫苗针对MDV超强毒株GX0101的免疫保护效果。
将120只1日龄的SPF鸡分为4组(每组30只),饲养于5个带有正压空气过滤装置的隔离器中。1日龄时,第1组每只鸡皮下接种2000 PFU的SC9-1;第2组每只鸡皮下接种2000 PFU的商用疫苗CVI988/Rispens。第3组和第4组不进行病毒攻毒,作为对照。5天后,第1、2、3组鸡经腹腔接种2000 PFU的MDV超强毒株GX0101。攻毒后90天内,记录所有死亡鸡只并进行剖检。对疑似肿瘤组织进行组织病理学活检。检测AIV和NDV疫苗接种诱导的抗体效价以及MDV GX0101的增殖动态。同时,对含有MDV母源抗体的海兰褐鸡进行平行试验。
SC9-1毒株在SPF鸡和海兰褐鸡中对MDV超强毒株GX0101攻毒提供了100%的保护效率。CVI988/Rispens疫苗在SPF鸡中对MDV超强毒株GX0101攻毒提供了86.7%的保护效率,在海兰褐鸡中为93%。用GX0101攻毒后,SPF鸡的死亡率为53.3%,出现肉眼可见肿瘤的鸡占16.7%;海兰褐鸡的死亡率为36.7%,出现肉眼可见肿瘤的鸡占16.7%,对照组组织病理学活检未发现肿瘤病变。qPCR结果显示,接种SC9-1的鸡淋巴细胞和毛囊DNA中GX0101病毒基因组拷贝数低于接种CVI988/Rispens的鸡。血凝抑制试验结果表明,接种SC9-1的鸡AIV和NDV抗体效价高于接种CVI988/Rispens的鸡。
在SPF鸡和含有母源抗体的商用海兰褐鸡中,SC9-1毒株对MDV的免疫保护效果优于CVI988/Rispens毒株。